“ardelyx” Archives

in
Entry Author Date Location
Biotech Roundup: BIO on Racism, AbbVie Antibodies, IPO Surge & More 06/12/20 National
Bio Roundup: mRNA Vaccine Data, Rise of Rallybio, Roche’s Protein Play & More 05/22/20 National
New BC Biotech Chinook Reels in $65M to Tackle Kidney Disease 08/22/19 National
Bio Roundup: CRISPR Ruling, “America’s Nobels,” IPOs & More 09/14/18 National
Bio Roundup: Light For Spark, California Drug Law, IPO Queue & More 10/13/17 National
Bio Roundup: CRISPR Drama, Marathon and PhRMA, the Price of Vision & More 02/17/17 National
West Coast Biotech Roundup: Regulus, Ardelyx, Juno, Sangamo & More 06/04/15 San Francisco
West Coast Biotech Roundup: Illumina, Veracyte, Otonomy, Kite & More 05/22/15 San Diego
West Coast Biotech Roundup: Tracon, Mirati, Third Rock, & Dendreon 02/06/15 San Diego
Ardelyx Obtains $60,200,000 New Round 06/19/14 San Francisco
West Coast Biotech Roundup: Ligand, Ardelyx, Mango Health, and More 05/23/14 San Diego
Ardelyx Nabs $30M To Develop Drug for Irritable Bowel Syndrome, and High Blood Pressure 08/31/11 San Francisco
Ardelyx Garners $30,000,000 Series B Funding 08/31/11 San Francisco
Ardelyx Collects $17.6M 07/11/11 San Francisco
Ardelyx Garners $17,578,665 Series B Financing Round 07/11/11 San Francisco
Ardelyx Obtains $5,013,694 New Financing Round 12/08/10 San Francisco
Ardelyx Secures $26,090,000 New Funding Round 06/30/08 San Francisco
Page 1 of 1